Example: Heart Attack
Clinical Trials on Retinal Vasculopathy With Cerebral Leukodystrophy
Total 1 results
-
NCT02723448CompletedConditions: Vasculopathy, Retinal, With Cerebral Leukodystrophy, Cerebroretinal Vasculopathy, Hereditary
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Acute Cardiac Event
- Advanced Tumor
- B Cells--Tumors
- Hemoglobinopathies
- High LDL-c
- Infection Viral
- Intra Ocular Pressure
- Medulloblastoma, Non-WNT/Non-SHH, Group 4
- Schnitzler Syndrome
- Spasm
- Stage III Childhood Anaplastic Large Cell Lymphoma
- Stress Disorders, Posttraumatic
- Therapeutic Irrigation
- View Full List
Sponsors and Collaborators
- Blade Therapeutics
- CSPC-NBP Pharmaceutical Co., Ltd.
- Chung-Ang University Hosptial, Chung-Ang University College of Medicine
- Denver Indian Health and Family Services
- Department of internal medicine, Central Hospital Bolzano, South Tyrol, Italy
- Laboratorios Thea, Spain
- Micelle BioPharma Inc
- Prof. Dr. med. Jochen Fiebach (Senior Physician)
- Research Unit of General Practice, Odense
- Riverview Health Centre
- SOMA Istituto Osteopatia Milano
- Stuart Knechtle, M.D.
- Tachista
- View Full List
Drug Interventions
- 3 months of dual antiplatelet therapy (DAPT)
- 320 mg PF-06473871
- ADASUVE®
- Bryostatin-1
- Fentanyl Buccal Tablet
- GSK2140944 placebo
- High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma
- LY2875358
- Lopinavir-ritonavir (LPV-RTV)
- Premarin reference tablet (fed)
- VX-984 240 mg + PLD 40 mg/m^2
- bimekizumab
- rV-PSA
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations